Skip to main content

TAP Partner News During ASH: Dec 2023

TAP Partner News During ASH: Dec 2023

ASH Highlights (click to learn more about each TAP partnership)

  • Affimed: clinical oral presentation of AFM13 in combination with allogeneic NK cells in CD30 HL & PTCL and poster presentation detailing Phase 2 trial in progress

  • Celator: multiple poster presentations on CPX-351 clinical results in AML, MPNs and high-risk MDS

  • Constellation: clinical oral presentation of Phase 3 MANIFEST-2 topline data in treatment-naive myelofibrosis and a poster presentation on patient-reported outcome from Phase 2 trial

  • Faron: clinical poster presentation of bexmarilimab in combo with SOC in AML and MDS

  • ImCheck: preclinical poster presentation of ICT01 to support Phase 2 expansion into 1L AML in combo with Ven/Aza

  • Immunitas: preclinical poster presentation of IMT-009 to support ongoing Phase 1 clinical trial

  • Kite: multiple oral and poster presentations of axi-cel in a variety of B-NHL indications, including FL and LBCL

  • Kura: two presentations of ziftomenib (KO-539) showcasing preclinical combination studies and a combination Phase 1 trial in progress

  • Kymera: clinical poster presentation of STAT3 degrader in TCL (PTCL and CTCL) and solid tumors and preclinical poster on combination approaches in AML

  • Ryvu: preclinical and clinical poster presentations of RVU120 in AML and MDS

  • Stemline: clinical poster presentation of tagrazofusp in CD123-positive AML

  • Vittoria: two oral and one poster presentations platform and preclinical data to support planned Phase 1 trial in TCL